IRIS
DE FABRITIIS, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.087
EU - Europa 2.581
AS - Asia 1.452
SA - Sud America 14
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 5
Totale 37.154
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.062
SG - Singapore 876
DE - Germania 533
IT - Italia 429
UA - Ucraina 425
IE - Irlanda 376
CN - Cina 367
RU - Federazione Russa 282
GB - Regno Unito 164
FI - Finlandia 94
KR - Corea 94
FR - Francia 82
SE - Svezia 79
JP - Giappone 26
PL - Polonia 22
AT - Austria 20
NL - Olanda 20
HK - Hong Kong 19
BE - Belgio 17
IN - India 16
CA - Canada 15
RO - Romania 11
TR - Turchia 10
UZ - Uzbekistan 8
VN - Vietnam 8
AU - Australia 6
CL - Cile 6
EU - Europa 6
GR - Grecia 6
MX - Messico 6
BR - Brasile 5
CZ - Repubblica Ceca 5
DM - Dominica 4
EG - Egitto 4
ES - Italia 4
IR - Iran 4
CH - Svizzera 3
ID - Indonesia 3
PT - Portogallo 3
BD - Bangladesh 2
HR - Croazia 2
IQ - Iraq 2
KG - Kirghizistan 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
QA - Qatar 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
EE - Estonia 1
JO - Giordania 1
KW - Kuwait 1
LT - Lituania 1
LV - Lettonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
Totale 37.154
Salva come PNG Salva come JPEG
Città #
Woodbridge 9.582
Wilmington 8.810
Houston 7.581
Fairfield 1.134
Ann Arbor 873
Singapore 765
Chandler 616
Ashburn 585
Seattle 472
Cambridge 395
Jacksonville 377
Dublin 358
Medford 265
Santa Clara 221
Dearborn 216
New York 155
Beijing 144
Rome 133
Lawrence 128
Colorado Springs 87
Zhengzhou 79
Moscow 66
Mülheim 65
San Diego 65
Menlo Park 46
Milan 44
Corona 34
Norwalk 25
London 24
University Park 23
Boardman 20
Falls Church 19
Brussels 17
Nanjing 17
Bologna 16
Hefei 16
Kraków 16
Los Angeles 16
Mountain View 16
Naples 16
Verona 16
Munich 15
Shanghai 15
Redwood City 13
Kunming 12
Hong Kong 11
Nuremberg 11
Washington 11
Palo Alto 10
Seoul 10
Chiswick 9
Creede 9
Vienna 9
Council Bluffs 8
Del Norte 8
Engelhard 8
Guangzhou 8
Hanoi 8
Helsinki 8
Nürnberg 8
Saint Petersburg 8
Chengdu 7
Frankfurt am Main 7
Groningen 7
Innsbruck 7
Jinan 7
Kilburn 7
Nanchang 7
Redmond 7
Toronto 7
Amsterdam 6
Turin 6
Brno 5
Chicago 5
Diyarbakır 5
Hounslow 5
Latina 5
Prescot 5
Salt Lake City 5
Teramo 5
Auburn Hills 4
Baotou 4
Birmingham 4
Chennai 4
Fuzhou 4
Lappeenranta 4
Montreal 4
Mumbai 4
Phoenix 4
Pont-Canavese 4
Rieti 4
Roseau 4
San Mateo 4
Athens 3
Bucharest 3
Chongqing 3
Fabriano 3
Hebei 3
Islington 3
Izmir 3
Totale 33.940
Salva come PNG Salva come JPEG
Nome #
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia 554
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 456
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia. 440
Cistite emorragica da Adenovirus in un paziente sottoposto a trapianto di midollo osseo. vol. 39, p. 977-978 440
Acute foetal distress and umbilical cord blood banking 439
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 439
Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA) 434
Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report 433
High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant 427
Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: Results of a randomized phase III trial of the EORTC and GIMEMA consortium (AML-17) 421
IgG secreting lymphoplasmacytoid leukemia with massive skin involvement and very aggressive clinical course: an exceptionally rare observation. 420
Bone marrow necrosis as a terminal complication of a very long-lasting polycythemia vera 420
Pure erythroid leukemia in advanced breast cancer. 418
Koebner's phenomenon as a rare mechanism of acute myeloid leukemia dissemination: report of two cases with a brief overview 415
Bortezomib-based therapy as induction regimen of an autograft program in front-line treatment of multiple myeloma with end-stage renal disease. 415
null 410
Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant 409
Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes 408
Management of hematological malignancies in patients affected by renal failure 407
Cutaneous involvement in multiple myeloma and bortezomib 406
Hodgkin disease subsequent to follicular lymphoma on maintenance rituximab 406
Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825 405
Characterization of Ph-negative abnormal clones emerging during imatinib therapy 405
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: Retrospective analysis of 530 patients 405
Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components 404
Cold autoimmune hemolytic anemia resolved by rituximab 400
Motor disability in malignant hematology: an epidemiological study on Italian hospitalized patients. 399
The prevention of oral mucositis in patients with blood cancers: current concepts and emerging landscapes 399
Unrelated Cord Blood transplantaion for children with high risk myelodysplastic syndrome 398
Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting. 395
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection 395
Bortezomib-related colon mucositis in a multiple myeloma patient 394
Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA). 393
Unexplained severe Coombs-negative hemolytic anemia during treatment of refractory chronic lymphocytic leukemia with alemtuzumab. 392
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 392
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis [6] 390
Complex and multifaceted therapy-related myeloid neoplasm following laryngeal cancer treated with Cisplatin and radiotherapy 390
CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF 387
Evaluation of biological features of cord blood units collected with different methods after cesarean section 385
null 385
Home care management of patients affected by hematologic malignancies: A review 381
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia 380
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation 379
Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors 378
Bortezomib: Efficacy comparisons in solid tumors and hematologic malignancies 377
A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry 377
Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phase 375
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies 372
Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autografting 370
breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis 368
Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusion 368
Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measures 366
Diagnosis of acute foetal distress does not preclude banking of umbilical cord blood units 365
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 365
Complete remission through blast cell differentiation in PLZF/RARα-positive acute promyelocytic leukemia: In vitro and in vivo studies 364
Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow 363
Molecular evidence of transient complete remission after autografting in Ph-/bcr rearranged chronic myelogenous leukaemia 363
Immunophenotypic analysis in 119 patients with acute myeloid leukemia following a previous malignancy: a comparison with the immunophenotype of 231 de novo cases 362
Triple immunofluorescence evaluation of CD15, CD34 and Class-II expression by flow-cytometry in normal and leukemic bone marrows 362
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. 360
The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemia 358
Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis 355
Opioids in pain management of blood-related malignancies 352
Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts 352
Sleep complaints in hospitalized Italian patients with hematological malignancies 351
Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy 346
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia 343
Homecare-based Motor Rehabilitation in Musculoskeletal Chronic Graft Versus Host Disease 341
Stem cell mobilization after coronary artery bypass grafting. 337
Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia 336
Primary pulmonary hodgkin lymphoma simulating a mediastinal tumour: an uncommon occurrence. 336
Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia [4] 335
Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial 330
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 329
Patient-reported outcomes and quality of life assessment: New targets for new targeted therapy? 326
DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE 324
Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation 323
Fibrin glue directly applied on damaged bladder mucosa during cystoscopy is highly effective to treat severe, refractory, haemorrhagic cystitis after allogeneic transplant 320
Extracorporeal photopheresis as first-line treatment in high-risk graft-versus-host disease 318
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. 316
Pain management in multiple myeloma. 299
Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825. 295
Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient 290
CD69 is independently prognostic in chronic lymphocytic leukemia: acomprehensive clinical and biological profiling study 286
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 266
The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network . 263
The potential application of the allogeneic transplant according to a widespread donor search policy: an intention-to-treat analysis from the Rome Transplant Network 262
Gender, age and diagnosis effect on self-perceived pain in hematological patients: Retrospective analysis of two case series 229
Pulmonary Infections in Patients with Myelodysplastic Syndromes Receiving Frontline Azacytidine Treatment 188
Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy 161
Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions 152
Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation 151
Chemotherapy induced nausea and vomiting in bone marrow transplant: the unmet need 143
Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the rome transplant network quality of life working party 141
MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES 140
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: Final results of the GIMEMA LAL 0904 study 138
Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant Network 134
Management of pregnant chronic myeloid leukemia patients 132
Bone marrow aspiration and biopsy-related pain management 130
Adherence to recommendation for chemotherapy-induced nausea and vomiting prophylaxis: the proposal of a score 128
Totale 34.581
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.375
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.575 0 0 0 0 744 979 790 769 985 854 724 730
2020/20216.244 671 727 700 771 623 706 742 660 144 197 232 71
2021/20221.280 61 170 54 52 45 113 76 76 70 103 80 380
2022/20231.956 184 144 60 184 124 370 153 91 142 344 118 42
2023/2024918 97 30 79 41 115 219 31 49 25 24 42 166
2024/20251.795 116 904 423 220 132 0 0 0 0 0 0 0
Totale 37.630